Contract Manufacturing

The pharmaceutical industry had an excellent showing in the Fast Company 2022 World-Changing Ideas Awards series, focusing on organizations dedicated to ‘social good.’ This year, the publication awarded three drug-delivery applications with awards, and Siemens took home a prize for its work in accelerating COVID-19 vaccine development. A 3D printed vaccine patch could deliver vaccine doses…

After receiving funding from the Bill & Melinda Gates Foundation, ProMed Pharma has begun preclinical evaluation of a novel fully resorbable contraceptive implant. The Plymouth, Minnesota–based company imagines that the contraceptive implants could ultimately find use in low- and middle-income (LMIC) settings. The novel implant potentially could offer women 18 months of contraception through the…

Pfizer (NYSE: PFE) has named David M. Denton as its new chief financial officer (CFO) and executive vice president. Denton, who now serves as CFO of Lowe’s Companies, will officially take the role on May 2. Before taking on his role at Lowe’s (NYSE:LOW), Denton served as the CFO of CVS Health (NYSE:CVS). Denton oversaw…

Pfizer (NYSE: PFE) announced that it would redirect all profits from its Russian subsidiary to relief efforts in Ukraine.  Concluding that pausing shipments of medicines to Russia would be counter to its principles, Pfizer had already decided to offer humanitarian efforts to Ukraine.  Pfizer also announced that it would refrain from launching new clinical trials…

Novartis (NYSE:NVS) has inked a deal with the biopharma Carisma Therapeutics focused on the production of human epidermal growth factor receptor 2 (HER2)-targeted chimeric antigen receptor macrophages (CAR-M) to potentially treat solid tumors. Carisma is headquartered in Philadelphia. As part of the deal, Carisma will shift manufacturing to a Novartis cell therapy site in Morris…

Moderna (Nasdaq:MRNA) announced four new initiatives within a global public health strategy for advancing mRNA vaccines. Cambridge, Massachusetts-based Moderna plans to expand its global public health portfolio, accelerate research in an effort to advance additional vaccines, expand its patent pledge to never enforce COVID-19 patents in the Gavi COVAX AMC for 92 low- and middle-income…

Johnson & Johnson (NYSE:JNJ) announced today that it completed an agreement for the manufacturing of its COVID-19 vaccine in Africa. The landmark agreement, made between Johnson & Johnson’s Janssen Pharmaceuticals and South Africa-based Aspen SA Operations, allows for the first COVID-19 vaccine to be manufactured and made available by an African company for people living…

The CDMO Asymchem Laboratories (Tianjin, China) Co., Ltd. has entered into an agreement to acquire Snapdragon Chemistry, a US-based chemical technology company. Asymchem will pay $57.94 million to acquire Snapdragon, which focuses on early-stage chemical process development services for the pharma and fine chemicals industries. “We believe continuous flow manufacturing is a revolutionary technology and…

The contract development and manufacturing organization Rentschler Biopharma (Laupheim, Germany) has begun constructing a new facility in Milford, Massachusetts, next to an existing facility. The new 22,000-ft2 facility will boost the company’s cGMP manufacturing capacity and its ability to produce complex molecules for U.S.-based clients. Once completed, the facility will contain space for manufacturing, single-use…

Johnson & Johnson (NYSE:JNJ) has decided to temporarily suspend production of its COVID-19 vaccine in Leiden in the Netherlands to prioritize production of an investigational respiratory syncytial virus (RSV) vaccine, according to The New York Times. The plant will resume production of its COVID-19 vaccine in a matter of months, the paper reported. The company is…